Quarterly report · Q2
2927.TEDINET S100QLNK
Period2022-09-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.4bn | 2022-09-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥23.0bn | 2021-09-01 → 2022-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.2bn | 2021-09-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | ¥678m | 2022-09-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥453m | 2021-09-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | ¥708m | 2022-09-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-09-01 → 2022-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥643m | 2021-09-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥616m | 2022-09-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥560m | 2021-09-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥414m | 2022-09-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥735m | 2021-09-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥307m | 2021-09-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥417m | 2022-09-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥307m | 2021-09-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥39.0bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥37.3bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥35.9bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥26.3bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥24.9bn | at 2022-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥12.6bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥12.4bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.9bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.4bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.8bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.6bn | at 2022-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2021-08-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥397m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥314m | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥791m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.2bn | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥924m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.2bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥774m | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥29.46 | 2022-09-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.01 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.33 | 2021-09-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.84 | 2021-09-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.8 | 2021-12-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥29.45 | 2022-09-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥52.08 | 2021-09-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥21.71 | 2021-09-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 32.3% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.2% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-09-01 → 2023-02-28 | ¥540m |
| Otherother segments | revenue external | 2022-09-01 → 2023-02-28 | ¥540m |
| Otherother segments | segment profit | 2022-09-01 → 2023-02-28 | −¥2m |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥13m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥698m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥698m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | segment profit | 2022-09-01 → 2023-02-28 | −¥121m |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥7.3bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥7.3bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥940m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥103m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-09-01 → 2023-02-28 | ¥12.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-09-01 → 2023-02-28 | ¥12.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-09-01 → 2023-02-28 | ¥933m |
| Otherother segments | revenue | 2021-09-01 → 2022-02-28 | ¥23m |
| Otherother segments | revenue external | 2021-09-01 → 2022-02-28 | ¥23m |
| Otherother segments | segment profit | 2021-09-01 → 2022-02-28 | −¥10m |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥2.3bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥2.3bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | segment profit | 2021-09-01 → 2022-02-28 | −¥122m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥441m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥441m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | segment profit | 2021-09-01 → 2022-02-28 | −¥190m |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥7.6bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥7.6bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | segment profit | 2021-09-01 → 2022-02-28 | ¥992m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥871m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥871m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | segment profit | 2021-09-01 → 2022-02-28 | ¥85m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-09-01 → 2022-02-28 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-09-01 → 2022-02-28 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-09-01 → 2022-02-28 | ¥755m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 536
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人アヴァンティア | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)戸 城 秀 樹 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)橋 本 剛 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 11202916000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 12444800000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 23024860000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 642760000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 708241000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1343193000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 307322000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 414054000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 735353000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 297684000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 375642000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 827256000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 12659252000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 12644959000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 12445149000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 35891451000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 38953015000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 37348660000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 21.84 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 29.46 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 52.33 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 21.71 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 29.45 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 52.08 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.331 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.323 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.332 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 313585000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 397356000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1492417000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -1201740000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -791130000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -1077917000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 773742000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 923657000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 1159612000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 8559377000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 10785778000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 10257778000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 10.80 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 18.01 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 14387699 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 14387699 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 14387699 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 14387699 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |